In which emerging direction do genetics and biomarkers guide individual treatment choices?

• A. Digital Health Interventions
• B. Personalized Medicine With Genetics And Biomarkers
• C. Integrated Care Models
• D. Polysubstance Use Focus

Answer: (B)

Tailoring treatment to individuals using genetic information and biomarkers. This approach, often called personalized or precision medicine with genetics and biomarkers, uses genetic variants and measurable biological indicators to predict who will respond to a medication, who may have risks for adverse effects, and what dosing might be most effective. In substance use disorders, this means selecting and dosing treatments based on a person’s genetic profile and biomarker data to optimize outcomes rather than relying on a one-size-fits-all plan.

The other directions focus on different aspects of care. Digital health interventions emphasize technology-enabled delivery and support, not genetic tailoring. Integrated care models prioritize coordinating services across settings and disciplines, rather than using biological markers to guide specific treatment choices. A polysubstance use focus centers on addressing multiple substances and the complexities that arise, rather than guiding therapy through genetics and biomarkers.